Global Policy Forum Members
Global Policy Forum Members
- Abbott Vascular
- AMGEN (Europe) GmbH
- AstraZeneca (UK) Ltd
- BioMarin Pharmaceutical Inc
- Boehringer Ingelheim
- Boston Scientific Corporation
- Bristol-Myers Squibb
- Edwards Lifesciences
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- GlaxoSmithKline
- Johnson & Johnson
- Medtronic
- Merck & Co
- Merck KGaA
- Novartis Pharma AG
- Pfizer Limited
- Sanofi Genzyme
- W. L. Gore & Associates
- AGENAS – Agenzia Nazionale per i Servizi Sanitari Regionali (Italy)
- AQuaS – Agency of Health Quality and Assessment of Catalonia (Spain)
- BC Cancer (Canada)
- BCBSA – Blue Cross Blue Shield Association (USA)
- CADTH – Canadian Agency for Drugs and Technologies in Health (Canada)
- CONITEC – National Committee for Technology Incorporation (Brazil)
- HAS – French National Authority for Health (France)
- Healthcare Improvement Scotland (UK)
- ICER – Institute for Clinical & Economic Review (USA)
- IETS – Institute of Technological Evaluation in Health (Colombia)
- INESS – The Institut National D’Excellence en Santé et en Services Sociaux (Canada)
- IQWiG – Institute for Quality and Efficiency in Health Care (Germany)
- NECA – National Evidence-based Healthcare Collaborating Agency (South Korea)
- NICE – National Institute for Health and Care Excellence (UK)
- NIPHNO – Norwegian Institute of Public Health Norway (Norway)
- PBAC & MSAC Australia Government, Department of Health and Ageing (Australia)
- PCORI – Patient-Centered Outcomes Research Institute (USA)
- Swedish Council on HTA (SBU) and Swedish Dental and Pharmaceutical Benefits Agency (TLV) – joint membership (Sweden)
- ZINL – National Health Care Institute (Netherlands)
Abbott Vascular International BVBA
AMGEN (Europe) GmbH
AstraZeneca (UK) Ltd
Boehringer Ingelheim
Boston Scientific Corporation
Bristol-Myers Squibb
Edwards Lifesciences
Eli Lilly and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline
Johnson & Johnson
Medtronic
Merck & Co
Merck KGaA
Novartis Pharma AG
Pfizer Limited
Sanofi Genzyme
W. L. Gore & Associates
BCBSA – Blue Cross Blue Shield Association (USA) International BVBA
CADTH – Canadian Agency for Drugs and Technologies in Health (Canada) (Europe)
CONITEC – National Committee for Technology Incorporation (Brazil)
HAS – French National Authority for Health (France)
Healthcare Improvement Scotland (UK)
HTAA – Health Technology Assessment Association (Russia)
ICER – Institute for Clinical & Economic Review (USA)
IQWiG – Institute for Quality and Efficiency in Health Care (Germany)
NECA – National Evidence-based Healthcare Collaborating Agency (South Korea)
NICE – National Institute for Health and Care Excellence (UK)
Johnson & Johnson
NIPHNO – Norwegian Institute of Public Health Norway (Norway)
PBAC & MSAC Australia Government, Department of Health and Ageing (Australia)
Merck KGaA
PCORI – Patient-Centered Outcomes Research Institute (USA)
Swedish Council on HTA (SBU) and Swedish Dental and Pharmaceutical Benefits Agency (TLV) – joint membership (Sweden)
ZINL – National Health Care Institute (Netherlands)
AQuaS – Agency of Health Quality and Assessment of Catal
Onia (Spain)
BC Cancer (Canada)
IETS – Institute of Technological Evaluation in Health (Colombia)
AGENAS – Agenzia Nazionale per i ServiziSanitari Regionali
HTAi is The ONLY Global Society Championing Equitable, Responsive, And Cutting-Edge Health Technology Assessment (HTA). As a community of multidisciplinary advisors, academics, scientists, professionals, public & private organizations, students, and citizen members.Everything we do is dedicated to better health for all people and the future of HTA worldwide.
Copyright © 2021. All Rights Reserved.
HTAi is The ONLY Global Society Championing Equitable, Responsive, And Cutting-Edge Health Technology Assessment (HTA). As a community of multidisciplinary advisors, academics, scientists, professionals, public & private organizations, students, and citizen members.Everything we do is dedicated to better health for all people and the future of HTA worldwide.
Copyright © 2021. All Rights Reserved.